Global RNA Drugs Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global RNA Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for RNA Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for RNA Drugs by Country/Region, 2017, 2022 & 2028

2.2 RNA Drugs Segment by Type

2.2.1 siRNA

2.2.2 ASO

2.2.3 miRNA

2.2.4 Nucleic Acid Aptamers

2.3 RNA Drugs Sales by Type

2.3.1 Global RNA Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global RNA Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global RNA Drugs Sale Price by Type (2017-2022)

2.4 RNA Drugs Segment by Application

2.4.1 Cancer

2.4.2 Diabetes

2.4.3 Tuberculosis

2.4.4 Cardiovascular Diseases

2.4.5 Others

2.5 RNA Drugs Sales by Application

2.5.1 Global RNA Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global RNA Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global RNA Drugs Sale Price by Application (2017-2022)

3 Global RNA Drugs by Company

3.1 Global RNA Drugs Breakdown Data by Company

3.1.1 Global RNA Drugs Annual Sales by Company (2020-2022)

3.1.2 Global RNA Drugs Sales Market Share by Company (2020-2022)

3.2 Global RNA Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global RNA Drugs Revenue by Company (2020-2022)

3.2.2 Global RNA Drugs Revenue Market Share by Company (2020-2022)

3.3 Global RNA Drugs Sale Price by Company

3.4 Key Manufacturers RNA Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers RNA Drugs Product Location Distribution

3.4.2 Players RNA Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for RNA Drugs by Geographic Region

4.1 World Historic RNA Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global RNA Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global RNA Drugs Annual Revenue by Geographic Region

4.2 World Historic RNA Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global RNA Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global RNA Drugs Annual Revenue by Country/Region

4.3 Americas RNA Drugs Sales Growth

4.4 APAC RNA Drugs Sales Growth

4.5 Europe RNA Drugs Sales Growth

4.6 Middle East & Africa RNA Drugs Sales Growth

5 Americas

5.1 Americas RNA Drugs Sales by Country

5.1.1 Americas RNA Drugs Sales by Country (2017-2022)

5.1.2 Americas RNA Drugs Revenue by Country (2017-2022)

5.2 Americas RNA Drugs Sales by Type

5.3 Americas RNA Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC RNA Drugs Sales by Region

6.1.1 APAC RNA Drugs Sales by Region (2017-2022)

6.1.2 APAC RNA Drugs Revenue by Region (2017-2022)

6.2 APAC RNA Drugs Sales by Type

6.3 APAC RNA Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe RNA Drugs by Country

7.1.1 Europe RNA Drugs Sales by Country (2017-2022)

7.1.2 Europe RNA Drugs Revenue by Country (2017-2022)

7.2 Europe RNA Drugs Sales by Type

7.3 Europe RNA Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa RNA Drugs by Country

8.1.1 Middle East & Africa RNA Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa RNA Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa RNA Drugs Sales by Type

8.3 Middle East & Africa RNA Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of RNA Drugs

10.3 Manufacturing Process Analysis of RNA Drugs

10.4 Industry Chain Structure of RNA Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 RNA Drugs Distributors

11.3 RNA Drugs Customer

12 World Forecast Review for RNA Drugs by Geographic Region

12.1 Global RNA Drugs Market Size Forecast by Region

12.1.1 Global RNA Drugs Forecast by Region (2023-2028)

12.1.2 Global RNA Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global RNA Drugs Forecast by Type

12.7 Global RNA Drugs Forecast by Application

13 Key Players Analysis

13.1 Pfizer

13.1.1 Pfizer Company Information

13.1.2 Pfizer RNA Drugs Product Offered

13.1.3 Pfizer RNA Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Pfizer Main Business Overview

13.1.5 Pfizer Latest Developments

13.2 Roche

13.2.1 Roche Company Information

13.2.2 Roche RNA Drugs Product Offered

13.2.3 Roche RNA Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Roche Main Business Overview

13.2.5 Roche Latest Developments

13.3 Sanofi-Aventis

13.3.1 Sanofi-Aventis Company Information

13.3.2 Sanofi-Aventis RNA Drugs Product Offered

13.3.3 Sanofi-Aventis RNA Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Sanofi-Aventis Main Business Overview

13.3.5 Sanofi-Aventis Latest Developments

13.4 Abbott Laboratories

13.4.1 Abbott Laboratories Company Information

13.4.2 Abbott Laboratories RNA Drugs Product Offered

13.4.3 Abbott Laboratories RNA Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Abbott Laboratories Main Business Overview

13.4.5 Abbott Laboratories Latest Developments

13.5 Arrowhead Pharmaceuticals

13.5.1 Arrowhead Pharmaceuticals Company Information

13.5.2 Arrowhead Pharmaceuticals RNA Drugs Product Offered

13.5.3 Arrowhead Pharmaceuticals RNA Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Arrowhead Pharmaceuticals Main Business Overview

13.5.5 Arrowhead Pharmaceuticals Latest Developments

13.6 Benitec Biopharma

13.6.1 Benitec Biopharma Company Information

13.6.2 Benitec Biopharma RNA Drugs Product Offered

13.6.3 Benitec Biopharma RNA Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Benitec Biopharma Main Business Overview

13.6.5 Benitec Biopharma Latest Developments

13.7 Calimmune Inc

13.7.1 Calimmune Inc Company Information

13.7.2 Calimmune Inc RNA Drugs Product Offered

13.7.3 Calimmune Inc RNA Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Calimmune Inc Main Business Overview

13.7.5 Calimmune Inc Latest Developments

13.8 Dicerna

13.8.1 Dicerna Company Information

13.8.2 Dicerna RNA Drugs Product Offered

13.8.3 Dicerna RNA Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Dicerna Main Business Overview

13.8.5 Dicerna Latest Developments

13.9 Gradalis

13.9.1 Gradalis Company Information

13.9.2 Gradalis RNA Drugs Product Offered

13.9.3 Gradalis RNA Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Gradalis Main Business Overview

13.9.5 Gradalis Latest Developments

13.10 Quark

13.10.1 Quark Company Information

13.10.2 Quark RNA Drugs Product Offered

13.10.3 Quark RNA Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Quark Main Business Overview

13.10.5 Quark Latest Developments

13.11 RXi

13.11.1 RXi Company Information

13.11.2 RXi RNA Drugs Product Offered

13.11.3 RXi RNA Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 RXi Main Business Overview

13.11.5 RXi Latest Developments

13.12 Senesco

13.12.1 Senesco Company Information

13.12.2 Senesco RNA Drugs Product Offered

13.12.3 Senesco RNA Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Senesco Main Business Overview

13.12.5 Senesco Latest Developments

13.13 Silence Therapeutics

13.13.1 Silence Therapeutics Company Information

13.13.2 Silence Therapeutics RNA Drugs Product Offered

13.13.3 Silence Therapeutics RNA Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Silence Therapeutics Main Business Overview

13.13.5 Silence Therapeutics Latest Developments

13.14 Silenseed

13.14.1 Silenseed Company Information

13.14.2 Silenseed RNA Drugs Product Offered

13.14.3 Silenseed RNA Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Silenseed Main Business Overview

13.14.5 Silenseed Latest Developments

13.15 Tekmira

13.15.1 Tekmira Company Information

13.15.2 Tekmira RNA Drugs Product Offered

13.15.3 Tekmira RNA Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Tekmira Main Business Overview

13.15.5 Tekmira Latest Developments

13.16 Alnylam Pharmaceuticals

13.16.1 Alnylam Pharmaceuticals Company Information

13.16.2 Alnylam Pharmaceuticals RNA Drugs Product Offered

13.16.3 Alnylam Pharmaceuticals RNA Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Alnylam Pharmaceuticals Main Business Overview

13.16.5 Alnylam Pharmaceuticals Latest Developments

14 Research Findings and Conclusion

Table 1. RNA Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. RNA Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of siRNA

Table 4. Major Players of ASO

Table 5. Major Players of miRNA

Table 6. Major Players of Nucleic Acid Aptamers

Table 7. Global RNA Drugs Sales by Type (2017-2022) & (K Units)

Table 8. Global RNA Drugs Sales Market Share by Type (2017-2022)

Table 9. Global RNA Drugs Revenue by Type (2017-2022) & ($ million)

Table 10. Global RNA Drugs Revenue Market Share by Type (2017-2022)

Table 11. Global RNA Drugs Sale Price by Type (2017-2022) & (USD/Unit)

Table 12. Global RNA Drugs Sales by Application (2017-2022) & (K Units)

Table 13. Global RNA Drugs Sales Market Share by Application (2017-2022)

Table 14. Global RNA Drugs Revenue by Application (2017-2022)

Table 15. Global RNA Drugs Revenue Market Share by Application (2017-2022)

Table 16. Global RNA Drugs Sale Price by Application (2017-2022) & (USD/Unit)

Table 17. Global RNA Drugs Sales by Company (2020-2022) & (K Units)

Table 18. Global RNA Drugs Sales Market Share by Company (2020-2022)

Table 19. Global RNA Drugs Revenue by Company (2020-2022) ($ Millions)

Table 20. Global RNA Drugs Revenue Market Share by Company (2020-2022)

Table 21. Global RNA Drugs Sale Price by Company (2020-2022) & (USD/Unit)

Table 22. Key Manufacturers RNA Drugs Producing Area Distribution and Sales Area

Table 23. Players RNA Drugs Products Offered

Table 24. RNA Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global RNA Drugs Sales by Geographic Region (2017-2022) & (K Units)

Table 28. Global RNA Drugs Sales Market Share Geographic Region (2017-2022)

Table 29. Global RNA Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global RNA Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global RNA Drugs Sales by Country/Region (2017-2022) & (K Units)

Table 32. Global RNA Drugs Sales Market Share by Country/Region (2017-2022)

Table 33. Global RNA Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global RNA Drugs Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas RNA Drugs Sales by Country (2017-2022) & (K Units)

Table 36. Americas RNA Drugs Sales Market Share by Country (2017-2022)

Table 37. Americas RNA Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas RNA Drugs Revenue Market Share by Country (2017-2022)

Table 39. Americas RNA Drugs Sales by Type (2017-2022) & (K Units)

Table 40. Americas RNA Drugs Sales Market Share by Type (2017-2022)

Table 41. Americas RNA Drugs Sales by Application (2017-2022) & (K Units)

Table 42. Americas RNA Drugs Sales Market Share by Application (2017-2022)

Table 43. APAC RNA Drugs Sales by Region (2017-2022) & (K Units)

Table 44. APAC RNA Drugs Sales Market Share by Region (2017-2022)

Table 45. APAC RNA Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC RNA Drugs Revenue Market Share by Region (2017-2022)

Table 47. APAC RNA Drugs Sales by Type (2017-2022) & (K Units)

Table 48. APAC RNA Drugs Sales Market Share by Type (2017-2022)

Table 49. APAC RNA Drugs Sales by Application (2017-2022) & (K Units)

Table 50. APAC RNA Drugs Sales Market Share by Application (2017-2022)

Table 51. Europe RNA Drugs Sales by Country (2017-2022) & (K Units)

Table 52. Europe RNA Drugs Sales Market Share by Country (2017-2022)

Table 53. Europe RNA Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe RNA Drugs Revenue Market Share by Country (2017-2022)

Table 55. Europe RNA Drugs Sales by Type (2017-2022) & (K Units)

Table 56. Europe RNA Drugs Sales Market Share by Type (2017-2022)

Table 57. Europe RNA Drugs Sales by Application (2017-2022) & (K Units)

Table 58. Europe RNA Drugs Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa RNA Drugs Sales by Country (2017-2022) & (K Units)

Table 60. Middle East & Africa RNA Drugs Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa RNA Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa RNA Drugs Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa RNA Drugs Sales by Type (2017-2022) & (K Units)

Table 64. Middle East & Africa RNA Drugs Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa RNA Drugs Sales by Application (2017-2022) & (K Units)

Table 66. Middle East & Africa RNA Drugs Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of RNA Drugs

Table 68. Key Market Challenges & Risks of RNA Drugs

Table 69. Key Industry Trends of RNA Drugs

Table 70. RNA Drugs Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. RNA Drugs Distributors List

Table 73. RNA Drugs Customer List

Table 74. Global RNA Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 75. Global RNA Drugs Sales Market Forecast by Region

Table 76. Global RNA Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global RNA Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas RNA Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 79. Americas RNA Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC RNA Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 81. APAC RNA Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe RNA Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Europe RNA Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa RNA Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Middle East & Africa RNA Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global RNA Drugs Sales Forecast by Type (2023-2028) & (K Units)

Table 87. Global RNA Drugs Sales Market Share Forecast by Type (2023-2028)

Table 88. Global RNA Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global RNA Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global RNA Drugs Sales Forecast by Application (2023-2028) & (K Units)

Table 91. Global RNA Drugs Sales Market Share Forecast by Application (2023-2028)

Table 92. Global RNA Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global RNA Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 94. Pfizer Basic Information, RNA Drugs Manufacturing Base, Sales Area and Its Competitors

Table 95. Pfizer RNA Drugs Product Offered

Table 96. Pfizer RNA Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 97. Pfizer Main Business

Table 98. Pfizer Latest Developments

Table 99. Roche Basic Information, RNA Drugs Manufacturing Base, Sales Area and Its Competitors

Table 100. Roche RNA Drugs Product Offered

Table 101. Roche RNA Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 102. Roche Main Business

Table 103. Roche Latest Developments

Table 104. Sanofi-Aventis Basic Information, RNA Drugs Manufacturing Base, Sales Area and Its Competitors

Table 105. Sanofi-Aventis RNA Drugs Product Offered

Table 106. Sanofi-Aventis RNA Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 107. Sanofi-Aventis Main Business

Table 108. Sanofi-Aventis Latest Developments

Table 109. Abbott Laboratories Basic Information, RNA Drugs Manufacturing Base, Sales Area and Its Competitors

Table 110. Abbott Laboratories RNA Drugs Product Offered

Table 111. Abbott Laboratories RNA Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 112. Abbott Laboratories Main Business

Table 113. Abbott Laboratories Latest Developments

Table 114. Arrowhead Pharmaceuticals Basic Information, RNA Drugs Manufacturing Base, Sales Area and Its Competitors

Table 115. Arrowhead Pharmaceuticals RNA Drugs Product Offered

Table 116. Arrowhead Pharmaceuticals RNA Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 117. Arrowhead Pharmaceuticals Main Business

Table 118. Arrowhead Pharmaceuticals Latest Developments

Table 119. Benitec Biopharma Basic Information, RNA Drugs Manufacturing Base, Sales Area and Its Competitors

Table 120. Benitec Biopharma RNA Drugs Product Offered

Table 121. Benitec Biopharma RNA Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 122. Benitec Biopharma Main Business

Table 123. Benitec Biopharma Latest Developments

Table 124. Calimmune Inc Basic Information, RNA Drugs Manufacturing Base, Sales Area and Its Competitors

Table 125. Calimmune Inc RNA Drugs Product Offered

Table 126. Calimmune Inc RNA Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 127. Calimmune Inc Main Business

Table 128. Calimmune Inc Latest Developments

Table 129. Dicerna Basic Information, RNA Drugs Manufacturing Base, Sales Area and Its Competitors

Table 130. Dicerna RNA Drugs Product Offered

Table 131. Dicerna RNA Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 132. Dicerna Main Business

Table 133. Dicerna Latest Developments

Table 134. Gradalis Basic Information, RNA Drugs Manufacturing Base, Sales Area and Its Competitors

Table 135. Gradalis RNA Drugs Product Offered

Table 136. Gradalis RNA Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 137. Gradalis Main Business

Table 138. Gradalis Latest Developments

Table 139. Quark Basic Information, RNA Drugs Manufacturing Base, Sales Area and Its Competitors

Table 140. Quark RNA Drugs Product Offered

Table 141. Quark RNA Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 142. Quark Main Business

Table 143. Quark Latest Developments

Table 144. RXi Basic Information, RNA Drugs Manufacturing Base, Sales Area and Its Competitors

Table 145. RXi RNA Drugs Product Offered

Table 146. RXi RNA Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 147. RXi Main Business

Table 148. RXi Latest Developments

Table 149. Senesco Basic Information, RNA Drugs Manufacturing Base, Sales Area and Its Competitors

Table 150. Senesco RNA Drugs Product Offered

Table 151. Senesco RNA Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 152. Senesco Main Business

Table 153. Senesco Latest Developments

Table 154. Silence Therapeutics Basic Information, RNA Drugs Manufacturing Base, Sales Area and Its Competitors

Table 155. Silence Therapeutics RNA Drugs Product Offered

Table 156. Silence Therapeutics RNA Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 157. Silence Therapeutics Main Business

Table 158. Silence Therapeutics Latest Developments

Table 159. Silenseed Basic Information, RNA Drugs Manufacturing Base, Sales Area and Its Competitors

Table 160. Silenseed RNA Drugs Product Offered

Table 161. Silenseed RNA Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 162. Silenseed Main Business

Table 163. Silenseed Latest Developments

Table 164. Tekmira Basic Information, RNA Drugs Manufacturing Base, Sales Area and Its Competitors

Table 165. Tekmira RNA Drugs Product Offered

Table 166. Tekmira RNA Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 167. Tekmira Main Business

Table 168. Tekmira Latest Developments

Table 169. Alnylam Pharmaceuticals Basic Information, RNA Drugs Manufacturing Base, Sales Area and Its Competitors

Table 170. Alnylam Pharmaceuticals RNA Drugs Product Offered

Table 171. Alnylam Pharmaceuticals RNA Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 172. Alnylam Pharmaceuticals Main Business

Table 173. Alnylam Pharmaceuticals Latest Developments

List of Figures

Figure 1. Picture of RNA Drugs

Figure 2. RNA Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global RNA Drugs Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global RNA Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. RNA Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of siRNA

Figure 10. Product Picture of ASO

Figure 11. Product Picture of miRNA

Figure 12. Product Picture of Nucleic Acid Aptamers

Figure 13. Global RNA Drugs Sales Market Share by Type in 2021

Figure 14. Global RNA Drugs Revenue Market Share by Type (2017-2022)

Figure 15. RNA Drugs Consumed in Cancer

Figure 16. Global RNA Drugs Market: Cancer (2017-2022) & (K Units)

Figure 17. RNA Drugs Consumed in Diabetes

Figure 18. Global RNA Drugs Market: Diabetes (2017-2022) & (K Units)

Figure 19. RNA Drugs Consumed in Tuberculosis

Figure 20. Global RNA Drugs Market: Tuberculosis (2017-2022) & (K Units)

Figure 21. RNA Drugs Consumed in Cardiovascular Diseases

Figure 22. Global RNA Drugs Market: Cardiovascular Diseases (2017-2022) & (K Units)

Figure 23. RNA Drugs Consumed in Others

Figure 24. Global RNA Drugs Market: Others (2017-2022) & (K Units)

Figure 25. Global RNA Drugs Sales Market Share by Application (2017-2022)

Figure 26. Global RNA Drugs Revenue Market Share by Application in 2021

Figure 27. RNA Drugs Revenue Market by Company in 2021 ($ Million)

Figure 28. Global RNA Drugs Revenue Market Share by Company in 2021

Figure 29. Global RNA Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 30. Global RNA Drugs Revenue Market Share by Geographic Region in 2021

Figure 31. Global RNA Drugs Sales Market Share by Region (2017-2022)

Figure 32. Global RNA Drugs Revenue Market Share by Country/Region in 2021

Figure 33. Americas RNA Drugs Sales 2017-2022 (K Units)

Figure 34. Americas RNA Drugs Revenue 2017-2022 ($ Millions)

Figure 35. APAC RNA Drugs Sales 2017-2022 (K Units)

Figure 36. APAC RNA Drugs Revenue 2017-2022 ($ Millions)

Figure 37. Europe RNA Drugs Sales 2017-2022 (K Units)

Figure 38. Europe RNA Drugs Revenue 2017-2022 ($ Millions)

Figure 39. Middle East & Africa RNA Drugs Sales 2017-2022 (K Units)

Figure 40. Middle East & Africa RNA Drugs Revenue 2017-2022 ($ Millions)

Figure 41. Americas RNA Drugs Sales Market Share by Country in 2021

Figure 42. Americas RNA Drugs Revenue Market Share by Country in 2021

Figure 43. United States RNA Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 44. Canada RNA Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 45. Mexico RNA Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 46. Brazil RNA Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 47. APAC RNA Drugs Sales Market Share by Region in 2021

Figure 48. APAC RNA Drugs Revenue Market Share by Regions in 2021

Figure 49. China RNA Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 50. Japan RNA Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 51. South Korea RNA Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 52. Southeast Asia RNA Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 53. India RNA Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 54. Australia RNA Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 55. Europe RNA Drugs Sales Market Share by Country in 2021

Figure 56. Europe RNA Drugs Revenue Market Share by Country in 2021

Figure 57. Germany RNA Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 58. France RNA Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 59. UK RNA Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 60. Italy RNA Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 61. Russia RNA Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 62. Middle East & Africa RNA Drugs Sales Market Share by Country in 2021

Figure 63. Middle East & Africa RNA Drugs Revenue Market Share by Country in 2021

Figure 64. Egypt RNA Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 65. South Africa RNA Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 66. Israel RNA Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 67. Turkey RNA Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 68. GCC Country RNA Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 69. Manufacturing Cost Structure Analysis of RNA Drugs in 2021

Figure 70. Manufacturing Process Analysis of RNA Drugs

Figure 71. Industry Chain Structure of RNA Drugs

Figure 72. Channels of Distribution

Figure 73. Distributors Profiles